Analyzing the prognosis of nearly 3,000 NSCLC patients (1,053 patients from TCGA LUAD and LUSC datasets and 2,004 patients from the AACR GENIE project), we determined that ARID1B mutation was not associated with prognosis in patients who did not receive ICIs (Fig. 1D, E). The gene discussed is ARID1B; the disease is non-small cell lung carcinoma.